Arrowstreet Capital’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,000
Closed -$228K 2309
2020
Q3
$228K Buy
+14,000
New +$229K ﹤0.01% 2182
2020
Q1
Sell
-14,100
Closed -$84K 1890
2019
Q4
$84K Buy
+14,100
New +$72.5K ﹤0.01% 1677

Other funds holding CGEN

Arrowstreet Capital's CGEN Position: Q4 2020 in Review

Arrowstreet Capital sold out of Compugen (CGEN) in Q4 2020, closing a stake of 14,000 shares — an estimated $228K sold.

Arrowstreet Capital first reported a position in CGEN in Q4 2019 and held it in 2 quarters. The position peaked at $228K in Q3 2020. 101 funds tracked by Wall St. Rank hold CGEN as of Q4 2020.

  • Arrowstreet Capital reported no remaining Compugen position as of Q4 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 14,000 Compugen shares in Q4 2020, an estimated $228K.
  • Arrowstreet Capital first reported a position in Compugen in Q4 2019 and held it in 2 quarters.
  • Arrowstreet Capital's Compugen position peaked at $228K in Q3 2020.
  • 101 funds tracked by Wall St. Rank held Compugen as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.